Home / News / CMS Belgium and CMS France advised Biogroup in connection...

CMS Belgium and CMS France advised Biogroup in connection with the acquisition of CMA-Medina

19/11/2020

CMS Belgium and CMS France advised Biogroup in connection with the acquisition of the Belgian clinical lab Group CMA-Medina. With this acquisition, the largest private clinical blood analysis groups in France and Belgium are joining forces. 

CMS acted as legal and tax advisor, alongside investment bank Degroof Petercam and financial advisors EY and KPMG.

The CMS team advising Biogroup in Belgium was lead by Arnaud Van Oekel and comprised David Prync, Candice Kunkera and Lola Verelst for the Corporate/M&A aspects, Bruno Fonteyn (regulatory), Sophie Berg (HR) and Olivier Querinjean and his team for the tax aspects.

The CMS France team comprised Christophe Blondeau, Benoit Gomel, Célia Mayran, Noëlle Boualem and Marion Bladé for the Corporate/M&A aspects and Jean-Charles Benois, Alexia Cayrel, Vincent Forestier and Thomas Louvel for the tax aspects.

Related people

Portrait ofArnaud Van Oekel
Arnaud Van Oekel
Partner
Brussels
Portrait ofDavid Prync
David Prync
Partner
Brussels
Portrait ofCandice Kunkera
Candice Kunkera
Senior Associate
Brussels
Portrait ofLola Verelst
Lola Verelst
Associate
Brussels
Portrait ofBruno Fonteyn
Bruno Fonteyn
Senior Associate
Brussels
Portrait ofSophie Berg
Sophie Berg
Partner
Brussels
Portrait ofOlivier Querinjean
Olivier Querinjean
Partner
Brussels
Show more Show less